FDA Inspection 1045001 — AbbVie Inc.
The FDA completed an inspection of AbbVie Inc. on February 16, 2018 in Wyandotte, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Wyandotte, MI (United States)